Replies to post #423571 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Correct, in absence of the mean to EOS endpoint outcome measures it would!

That would be terrible if Anavex added more Odds Ratios to highlight the Rett patients who have IMPROVED while taking blarcamesine... now wouldn't it?

But it would likely yet again be very good for your reloading with dry powder strategy